Arthur Viodé
Impact in
- Physiology top 5%
- Alzheimer's disease research and treatments
- Spectroscopy top 5%
- Advanced Proteomics Techniques and Applications
- Mass Spectrometry Techniques and Applications
Papers in
-
- COVID-19 Clinical Research Studies 7
- SARS-CoV-2 and COVID-19 Research 2
-
- Advanced Proteomics Techniques and Applications 5
- Mass Spectrometry Techniques and Applications 3
- Co-authors
- Hanno Steen (7 shared papers)Judith A. J. Steen (7 shared papers)Patrick van Zalm (6 shared papers)Kinga K. Smolen (4 shared papers)Ofer Levy (3 shared papers)Benoit Fatou (3 shared papers)François Bécher (4 shared papers)Christoph N. Schlaffner (3 shared papers)
- Journals
- Nature Communications (3 papers)Science Advances (2 papers)The Analyst (2 papers)Journal of Thoracic Oncology (1 paper)Science Translational Medicine (1 paper)
- Partner nations
- United StatesFranceNetherlands
In The Last Decade
Arthur Viodé
22 papers receiving 667 citations
Arthur Viodé's Hit Papers
Peers
Comparison fields: 5 of 58
- Physiology 336
- Spectroscopy 104
- Neurology 77
- Infectious Diseases 68
- Psychiatry and Mental health 48
Countries citing papers authored by Arthur Viodé
This map shows the geographic impact of Arthur Viodé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arthur Viodé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arthur Viodé more than expected).
Fields of papers citing papers by Arthur Viodé
This network shows the impact of papers produced by Arthur Viodé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arthur Viodé. The network helps show where Arthur Viodé may publish in the future.
Co-authors
The 25 scholars most cited alongside Arthur Viodé, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease Hit paper breakdown → | 2020 | 328 |
| 2 | 2023 | 77 | |
| 3 | 2024 | 38 | |
| 4 | 2023 | 33 | |
| 5 | 2023 | 33 | |
| 6 | 2018 | 25 | |
| 7 | 2015 | 21 | |
| 8 | 2024 | 18 | |
| 9 | 2024 | 16 | |
| 10 | 2017 | 15 | |
| 11 | 2019 | 14 | |
| 12 | 2024 | 14 | |
| 13 | 2022 | 12 | |
| 14 | 2024 | 12 | |
| 15 | 2018 | 10 | |
| 16 | 2022 | 6 | |
| 17 | 2024 | 5 | |
| 18 | 2025 | 5 | |
| 19 | 2022 | 3 | |
| 20 | 2026 | 2 |
About Arthur Viodé
Arthur Viodé is a scholar working on Infectious Diseases, Spectroscopy, Physiology, Neurology and Applied Microbiology and Biotechnology, having authored 25 papers that have together received 690 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (7 papers), Alzheimer's disease research and treatments (7 papers), Advanced Proteomics Techniques and Applications (5 papers), Long-Term Effects of COVID-19 (3 papers), Mass Spectrometry Techniques and Applications (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), HIV Research and Treatment (1 paper) and Cytomegalovirus and herpesvirus research (1 paper). The work is most often cited by research in Physiology (336 citations), Spectroscopy (104 citations), Neurology (77 citations), Infectious Diseases (68 citations) and Psychiatry and Mental health (48 citations). Arthur Viodé has collaborated with scholars based in United States, France and Netherlands. Frequent co-authors include Hanno Steen, Judith A. J. Steen, Patrick van Zalm, Kinga K. Smolen, Ofer Levy, Benoit Fatou, François Bécher, Christoph N. Schlaffner, Christophe Junot and François Fenaille. Their work appears in journals such as Nature Communications, Science Advances, The Analyst, Journal of Thoracic Oncology and Science Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.